Literature DB >> 8781896

Hepatitis E virus: molecular biology and diagnosis.

I K Mushahwar1, G J Dawson, G R Reyes.   

Abstract

The hepatitis E virus (HEV) is a cause of severe liver disease in humans, especially in developing countries. Several assays are available to detect the HEV genome and specific antibodies against HEV (anti-IgG, IgA and IgM). Different serological patterns enable the diagnostician to differentiate remote from recent infections. In order to avoid diagnostic errors based on incomplete serological diagnosis, these patterns are shown with their specific serological marker.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781896

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.

Authors:  M Herremans; E Duizer; E Jusic; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

2.  Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic.

Authors:  C C Lin; J C Wu; T T Chang; W Y Chang; M L Yu; A W Tam; S C Wang; Y H Huang; F Y Chang; S D Lee
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.

Authors:  Min Zhao; Xiao-Jing Li; Zi-Min Tang; Fan Yang; Si-Ling Wang; Wei Cai; Ke Zhang; Ning-Shao Xia; Zi-Zheng Zheng
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

Review 4.  Transmission, diagnosis, and management of hepatitis E: an update.

Authors:  Santiago Mirazo; Natalia Ramos; Victoria Mainardi; Solange Gerona; Juan Arbiza
Journal:  Hepat Med       Date:  2014-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.